A phase II study of triapine for advanced adenocarcinoma of the pancreas
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2013
At a glance
- Drugs OCX 191 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2012 Planned number of patients changed from 48 to 116 as reported by ClinicalTrials.gov record.
- 11 Jan 2007 Status change